We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,756 hedge funds and large institutions have $252B invested in Johnson & Johnson in 2019 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 1,129 increasing their positions, 1,289 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 66

4.93% more ownership

Funds ownership: 68.05%72.98% (+4.9%)

0% less funds holding

Funds holding: 2,7662,756 (-10)

0% less capital invested

Capital invested by funds: $253B → $252B (-$1.14B)

7% less funds holding in top 10

Funds holding in top 10: 690639 (-51)

11% less call options, than puts

Call options by funds: $1.69B | Put options by funds: $1.9B

12% less repeat investments, than reductions

Existing positions increased: 1,129 | Existing positions reduced: 1,289

Holders
2,756
Holders Change
-10
Holders Change %
-0.36%
% of All Funds
59.85%
Holding in Top 10
639
Holding in Top 10 Change
-51
Holding in Top 10 Change %
-7.39%
% of All Funds
13.88%
New
91
Increased
1,129
Reduced
1,289
Closed
66
Calls
$1.69B
Puts
$1.9B
Net Calls
-$208M
Net Calls Change
+$260M
Name Holding Trade Value Shares
Change
Change in
Stake
CCP
1151
Clifford Capital Partners
Utah
$5.34M +$126K +908 +2%
ECM
1152
Exchange Capital Management
Michigan
$5.34M +$2.35K +17 +0%
MIC
1153
MU Investments Company
Japan
$5.33M +$96.9K +700 +2%
Qube Research & Technologies (QRT)
1154
Qube Research & Technologies (QRT)
United Kingdom
$5.33M -$8.15M -58,844 -61%
BRCM
1155
Bright Rock Capital Management
Massachusetts
$5.33M -$692K -5,000 -12%
VST
1156
Van Strum & Towne
California
$5.32M
AIM
1157
Anchor Investment Management
South Carolina
$5.32M -$8.3K -60 -0.2%
BCM
1158
Brookstone Capital Management
Illinois
$5.31M +$2.25M +16,221 +74%
NI
1159
Nepsis Inc
Minnesota
$5.3M -$482K -3,479 -8%
UFG
1160
United Fire Group
Iowa
$5.29M
SCP
1161
Shorepoint Capital Partners
Massachusetts
$5.29M -$384K -2,775 -7%
CLOS
1162
Compagnie Lombard Odier SCmA
Switzerland
$5.28M -$1.12M -8,111 -18%
KTC
1163
Kistler-Tiffany Companies
Pennsylvania
$5.27M -$42.2K -305 -0.8%
HPIA
1164
Hamilton Point Investment Advisors
North Carolina
$5.26M +$171K +1,234 +3%
APP
1165
Avantax Planning Partners
Iowa
$5.25M +$2.63K +19 +0.1%
BWP
1166
Baldwin Wealth Partners
Massachusetts
$5.25M -$282K -2,035 -5%
JWM
1167
JGP Wealth Management
Oregon
$5.25M +$162K +1,170 +3%
BIA
1168
Biondo Investment Advisors
Pennsylvania
$5.23M -$26K -188 -0.5%
MHIM
1169
MacNealy Hoover Investment Management
Ohio
$5.23M -$18K -130 -0.3%
RMAM
1170
Raab & Moskowitz Asset Management
New Jersey
$5.22M +$51.6K +373 +1%
FAM
1171
Fred Alger Management
New York
$5.22M +$1.55M +11,185 +43%
SC
1172
Sepio Capital
Utah
$5.21M +$585K +4,228 +13%
CHAM
1173
Clear Harbor Asset Management
Connecticut
$5.21M -$618K -4,466 -11%
PC
1174
Pecaut & Co
Iowa
$5.21M +$24.5K +177 +0.5%
AIA
1175
Allied Investment Advisors
Montana
$5.2M -$156K -1,125 -3%

JNJ Hedge Fund Activity: Q2 2019 in Review

2,756 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2019, worth a combined $252B — down 0.45% from $253B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new JNJ positions and 66 closed out — a net gain of 25 holders — while 1,129 added to existing stakes and 1,289 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $17.3B. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $719M.

  • 2,756 institutional investors held Johnson & Johnson (JNJ) as of Q2 2019, down from 2,766 in Q1 2019.
  • Funds reported $252B of Johnson & Johnson stock for Q2 2019, down 0.45% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q2 2019 and 66 closed out, a net change of +25 holders.
  • The largest Johnson & Johnson buyer in Q2 2019 was Phocas Financial Corp, an estimated $17.3B added.
  • The largest Johnson & Johnson seller in Q2 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $719M sold.

Based on aggregated 13F filings for Q2 2019.